IFRX – inflarx n.v. (US:NASDAQ)
Stock Stats
News
4/30
07:39 am
ifrx
Low
InflaRx to Host Virtual R&D Event on June 5, 2024 and Report First Quarter 2024 Results on May 8, 2024 [Yahoo! Finance]
4/30
07:30 am
ifrx
Medium
InflaRx to Host Virtual R&D Event on June 5, 2024 and Report First Quarter 2024 Results on May 8, 2024
4/24
07:30 am
ifrx
Low
InflaRx to Participate in Capital One Securities 1st Annual Biotech/Biopharma Disrupters Event
4/19
06:34 am
ifrx
Medium
Global Sepsis Therapeutics Strategic Research Report 2024: Market to Reach $7.1 Billion by 2030 - Market Receives Pulsating Impetus from North America, Asia-Pacific to Witness Fastest Growth [Yahoo! Finance]
3/22
08:22 am
ifrx
Low
InflaRx (NASDAQ: IFRX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $8.00 price target on the stock.
8/10/2023
07:30 am
ifrx
-7.0%
BEAT
5/11/2023
07:30 am
ifrx
7.2%
BEAT
3/22
08:22 am
Reiterates
Buy
Buy
HC Wainwright
Low
-2.6%
4/25
04:16 pm
ifrx
Medium
Form 6-K InflaRx N.V. For: Apr 25
4/4
04:02 pm
ifrx
Low
Form 6-K InflaRx N.V. For: Apr 04
3/21
05:02 pm
ifrx
Medium
Form 6-K InflaRx N.V. For: Mar 21
3/21
07:29 am
ifrx
Medium
Form 20-F InflaRx N.V. For: Dec 31
3/21
07:05 am
ifrx
Medium
Form 6-K InflaRx N.V. For: Mar 21
Show more
Top News Gainers
3/31 InflaRx Doses First Patient in Multicenter Randomized Clinical Trial in Severe Progressed COVID-19 Pneumonia in Europe upon Receipt of Initial Positive Human Data with InflaRx’s anti-C5a Technology 50.0%
4/29 Form 20-F InflaRx N.V. For: Dec 31 30.0%
2/14 Form SC 13G/A InflaRx N.V. Filed by: Cormorant Asset Management, LP 23.6%
2/19 InflaRx to Present at Upcoming SVB Leerink Global Healthcare Conference 14.9%
2/26 Form 6-K InflaRx N.V. For: Feb 26 14.1%
6/12 Inflarx NV (NASDAQ: IFRX) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $3.75 price target on the stock. 6.1%
1/8 Inflarx NV (NASDAQ: IFRX) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $4.00 price target on the stock. 5.2%
10/23 Inflarx NV (NASDAQ: IFRX) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 4.9%
6/14 Form 6-K InflaRx N.V. For: Jun 14 4.7%
6/13 InflaRx Treats First Patient in Phase IIa Clinical Trial with Lead Candidate IFX-1 in Pyoderma Gangraenosum 3.6%
Top News Decliners
6/5 Form 6-K InflaRx N.V. For: Jun 05 -91.8%
4/1 Form 6-K InflaRx N.V. For: Mar 31 -34.4%
3/2 Form 6-K InflaRx N.V. For: Mar 02 -23.5%
11/7 Form 6-K InflaRx N.V. For: Nov 07 -21.7%
7/18 Form 6-K InflaRx N.V. For: Jul 18 -16.0%
5/23 Form 6-K InflaRx N.V. For: May 23 -10.2%
4/29 InflaRx Reports Full Year 2019 Financial & Operating Results -7.8%
11/14 Form 6-K InflaRx N.V. For: Nov 14 -5.3%
4/9 Form 6-K InflaRx N.V. For: Apr 09 -3.1%
2/26 InflaRx Announces Positive Initial Data from Ongoing Phase IIa Open Label Study with IFX-1 in Patients Suffering from Pyoderma Gangraenosum -3.0%
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.
Click Here To Register For The Live Online Workshop
In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

20715 N Pima Rd #F108
Scottsdale, AZ 85255
Email: info@newsquantified.com
Copyright Ⓒ News Quanitifed LLC. 1.1.3